Insights on FRTX
Increasing Revenue
Revenue is up for the last 3 quarters, 9.0K → 7.94M (in $), with an average increase of 91.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 2.10M → -1.23M (in $), with an average decrease of 158.8% per quarter
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 20.4%
Highlights
Market Capitalization | 5.3M |
Book Value | $1.66 |
Earnings Per Share (EPS) | -1.06 |
Wall Street Target Price | 4.5 |
Profit Margin | -71.12% |
Operating Margin TTM | -79.44% |
Return On Assets TTM | -36.37% |
Return On Equity TTM | -66.5% |
Revenue TTM | 8.0M |
Revenue Per Share TTM | 1.48 |
Quarterly Revenue Growth YOY | -100.0% |
Gross Profit TTM | -27.8M |
EBITDA | -6.3M |
Diluted Eps TTM | -1.06 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Moderna, Inc. | 21.03% | 85.08% | 14.68% | -28.27% | 659.22% |
 Regeneron Pharmaceuticals, Inc. | 3.22% | 20.18% | 31.88% | 93.3% | 227.58% |
 Novo Nordisk A/s | 8.85% | 34.38% | 71.83% | 235.07% | 463.44% |
 Vertex Pharmaceuticals Incorporated | 16.81% | 34.1% | 40.6% | 123.97% | 174.53% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Moderna, Inc. | Buy | $54.6B | 659.22% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 227.58% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 463.44% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 174.53% | 29.59 | 39.46% |
Discover More
Keyarch Acquisition Corp
$0.88
-1.0%
Connexa Sports Technologies Inc
$0.88
-1.0%
Us Value Etf
$0.88
-1.0%
First Wave Biopharma Inc
$0.88
-1.0%
Global X Msci Next Emerging
$0.88
-1.0%
Fat Projects Acquisition Corp
$0.88
-1.0%
Goal Acquisitions Corp
$0.88
-1.0%
Capital Link Global Fintech
$0.88
-1.0%
Applied Uv Inc
$0.88
-1.0%